Molecular Targets for Antibody-Based Anti-Biofilm Therapy in Infective Endocarditis
Infective endocarditis (IE) is a heart disease caused by the infection of heart valves, majorly caused by <i>Staphilococcus aureus</i>. IE is initiated by bacteria entering the blood circulation in favouring conditions (e.g., during invasive procedures). So far, the conventional antimicr...
Main Authors: | Jiahe Han, Alessandro Poma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Polymers |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4360/14/15/3198 |
Similar Items
-
Advances in medicine and positive natural selection: Prosthetic valve endocarditis due to biofilm producer Micrococcus luteus
by: Guillermo Rodriguez-Nava, et al.
Published: (2020-01-01) -
Infective Endocarditis in Children — New Approach in Antimicrobial Prophylaxis
by: Togănel Rodica
Published: (2016-06-01) -
Nanoparticle, a promising therapeutic strategy for the treatment of infective endocarditis
by: Qi Tong, et al.
Published: (2022-02-01) -
Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome
by: Christian Johann Lerche, et al.
Published: (2021-06-01) -
Streptococcus mutans isolated from a 4‐year‐old girl diagnosed with infective endocarditis
by: Yoshio Kondo, et al.
Published: (2019-10-01)